ABSTRACT
disease and stroke risk factor.
1,2 It is now recognized that tobacco use has a broader impact beyond that of disease development. Tobacco contributes to a poorer prognosis, increased all-cause and cancerspecific mortality, and increased risk of second primary tumors and is thought to negatively influence cancer treatment outcomes and disease recurrence among those with a diagnosis of cancer. 2 It is important to examine the impact of a cancer diagnosis and its potential use as a powerful teachable moment for smoking cessation interventions, given the wideranging influence of smoking on important clinical outcomes. The impact of a cancer diagnosis, especially one related to tobacco use, can serve as an opportune teachable moment and may result in a population more receptive to a tobacco cessation intervention and more motivated to attempt to quit or stay quit. [3] [4] [5] Historically, tobacco cessation efforts following a cancer diagnosis have received little attention. A small number of studies demonstrated that the smoking rates among cancer patients and survivors are similar to or higher than that of the general population. 6, 7 Up to approximately 60% of cancer patients continue using tobacco products after their diagnosis of cancer, with varying rates depending on the cancer site. 4, 6 Among lung cancer patients specifically, continued smoking after their cancer diagnosis varies greatly in the published literature, ranging from 19% to 85%. [7] [8] [9] Unlike the majority of studies wherein newly diagnosed patients are given the opportunity to opt-in to a cessation program, this observational study describes an opt-out program where all patients are screened for tobacco use and offered cessation assistance. [9] [10] [11] [12] [13] [14] Opt-out designs remove self-selection into the cessation assistance programs compared with opt-in, which depends on the patient proactively calling for telephone-based cessation program. For example, the Ask-Advise-Connect model has shown to dramatically increase patient enrollment into quitline services when integrated into the primary care setting compared with Ask-Advise-Refer. 15, 16 In October 2010, Roswell Park Cancer Institute (RPCI) established a policy requiring the systematic assessment of tobacco use and automated electronic referral to a dedicated tobacco cessation support service for thoracic cancer center patients as well as patients with other tobaccorelated cancers. This article presents data from a cessation support service to examine the following: (1) the reach by examining the proportion of referred and participating thoracic cancer center patients; and (2) the impact by examining the change in quit rate from the first cessation support call to follow-up, as well as the characteristics of continued users compared with those who quit at follow-up.
Methods

Data collection
Starting in October 2010, all RPCI thoracic cancer center patients were systematically screened for tobacco use. This included patients with thoracic malignancies, lung cancer screening patients, undiagnosed patients, and patients with pulmonary diseases. Thoracic cancer center nurses administer a standardized tobacco use assessment using the electronic medical record (EMR) for every patient and update that information every 30 days thereafter. 17 Patients who report using tobacco currently or in the past 30 days are automatically referred to the cessation support service via the EMR. Additional information on the cessation support service can be found elsewhere. [17] [18] [19] Patients referred to the cessation support service are mailed a welcome packet with information about the free program, the impact of smoking on overall health and specifically on cancer treatment, pharmacologic cessation support options, and information on the New York State Smokers' Quitline, where immediate support is available. Because of staffing limitations, new thoracic cancer center patients who were current daily users had call priority. If patients were not reached after 9 call attempts, they were classified as "not reached" and mailed another letter describing the service, again highlighting the benefits of quitting, and inviting them to call if they are interested in cessation support. The cessation specialist tailored conversations to the needs of each patient, while discussing the impact of continued smoking on cancer treatment and outcomes and obtaining information on tobacco use and quitting history, barriers to quitting, and willingness to quit. The cessation specialist assisted patients in making a quit plan that included techniques to reduce behaviors that promote smoking, implement strategies for coping with cravings, and obtaining pharmacologic support if eligible. If a patient recently quit, the cessation specialist used similar techniques to encourage the maintenance of a patient's quit status.
The cessation specialist provided up to 7 additional follow-up support calls with patients. As a patientcentered service, there is no specific protocol for frequency, duration, or content of the counseling calls. Cessation specialists tailored the frequency and duration of follow-up contact to individual patient needs, which are made, on average, every 6 weeks. Patients have an option to opt out of the program at any time after the referral.
Sample
Patients met the following criteria for inclusion in this study: (1) classified as a new patient for the tobacco use assessment; and (2) a cessation service referral generated between October 1, 2010, and October 31, 2012, from the RPCI thoracic cancer center. Patients directly referred to the cessation service by a clinician in the thoracic cancer center between October 1, 2010, and October 31, 2012 (n = 46), were also eligible for inclusion. In addition, to be included in the analysis for the second objective, patients must have participated in at least 2 telephone calls by August 2013 (ie, the first cessation support call and a follow-up cessation support call).
Patients seen at the RPCI thoracic cancer center include those diagnosed with or suspected of having a thoracic malignancy, persons participating in the high-risk lung cancer screening program, as well as undiagnosed patients and patients with pulmonary diseases. Ineligible patients include those enrolled in hospice or end-of-life care, leaving RPCI for treatment elsewhere, referred patients for whom only family members or assisted living facility staff could be contacted, established patients screened at follow-up visits, or inaccurate referrals (ie, quit years ago, occasional smokers). Established patients were those patients who had already initiated cancer treatment and were presenting to the thoracic cancer center after initial consultation for cancer care. We excluded established patients from this analysis because call priority was given to patients referred to the cessation service with the new patient screen rather than the established patient screen. Also, only new patients, rather than new and established, were included in these analyses since they received smoking cessation assistance closer to the time of diagnosis than established patients did.
Statistical analysis
Demographic and health information was obtained from the EMR (age, pack-years, referral date, smoking status at referral, Eastern Cooperative Oncology Group [ECOG] performance status), the RPCI billing database (sex, date of birth, race, ethnicity, marital status), and the RPCI cancer registry (cancer status). Race and ethnicity were self-reported during patient registration. The main outcome variable, quit status at first and follow-up cessation support calls, was obtained from the cessation service records. A patient was considered quit if he or she self-reported being smoke-free for at least the last 7 days prior to the first or follow-up cessation support calls. Marital status was recoded as single or married; patients of other marital situations, such as being widowed, divorced, or separated, were included in the single category. ECOG performance status was dichotomized into 0 (healthy individual with no physical restrictions) and scores of 1 or greater (patients with limited physical restrictions to completely disabled or deceased). 20 There is no comparison group for this observational study since this program was implemented as standard of care. Data were linked by the patient medical record number, compiled into the main data set, and de-identified. The RPCI institutional review board approved this study.
Descriptive and multivariate statistics were used to characterize (1) the proportion of referred and participating thoracic cancer center patients; and (2) the selfreported 7-day quit rates at the time of referral and at the first and follow-up cessation support calls and the characteristics of current smokers compared with those who reported quitting at follow-up. Chi-square tests were used to examine the differences in categorical demographic and health behavior variables between current users and those who quit at each time point. An exact McNemar test was used to determine the difference in self-reported smoking status at each contact. A multivariate logistic regression model was used to describe characteristics associated with quitting at follow-up among current users at referral and the first cessation support call. Data were analyzed using SPSS v20.
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Results
Reach of the cessation support service
Between October 2010 and October 2012, a total of 1313 patients were referred from the thoracic cancer center to the cessation support service, of which 1258 referrals were eligible to be contacted by the cessation service as new patients (Figure 1 ). Attempts were made to contact 942 of 1258 (74.9%) by telephone. Of 1258 referrals, 316 (25.1%) were not called because of staffing limitations but were still mailed the welcome packet.
Of the 942 patients with at least 1 contact attempt, 730 (77.5%) participated in 1 cessation support telephone call (Figure 1) . One hundred twelve (11.9%) of the 942 patients with whom a contact was attempted could not be reached, 49 of 942 (5.2%) patients were in an end-of-life situation or deceased and 22 of 942 (2.3%) patients actively refused participation. Twenty-nine (3.1%) of the 942 patients were considered inappropriate referrals once contacted (ie, never or occasional tobacco users, or quit more than 30 days prior to referral). An average of 35.9 days (SD = 79.5; median = 14 days; range, 0-812 days) elapsed between referral and the first cessation support call, and there was an average of 1.6 calls attempted per patient. Patients who participated in the first cessation support call tended to be female (n = 384/478; 80.3%) compared with male (n = 341/457; Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. The average number of days between referral and the first cessation support call for all thoracic cancer center patients is 35.9 days, with a median 14 days and an average of 1.63 call attempts made. The average number of days between the first cessation support call and follow-up for all thoracic cancer center patients is 49.3 days, with a median of 21 days and an average of 1.8 call attempts made. b Those who refused participation either hung up on the cessation support service cessation specialists or said they were not interested in participating/"do not bother me again" . n = 14 answered call 1 and said do not bother me again but completed the phone call enough for the stage of change to be assessed (n = 1 had quit for at least 7 days prior to contact, n = 9 were in precontemplation, and n = 4 were in preparation). n = 5 hung up before the stage of change could be assessed, and n = 3 said do not bother me again because they were no longer patients at the Roswell Park Cancer Institute. c Among inappropriate referrals n = 25 quit years ago, n = 3 were never users, and n = 1 was an occasional smoker. d In total, 41.8% of patients referred and called for at least once cessation support call participated in a follow-up call (394/942). n = 7 participants were not reached in the first call and proactively called the cessation service after being sent a "no reach" letter inviting them to participate in the free service but were not included in the final analyses.
74.6%; P = .036) and white (n = 646/818; 79.0%) compared with any other race (n = 76/117; 67.5%; P = .005; results not shown).
Follow-up cessation support calls were attempted for 440 of the 730 successfully reached for the first cessation support call (60.3%), of which 394 of 440 (89.5%) participated in the follow-up call (Figure 1) . The remaining 290 of 730 (39.7%) were not called for a follow-up because of staffing limitations. Of note, 7 patients proactively called the cessation support service after they were sent a "no reach" letter explaining the program with an invitation to call for cessation support, but these patients were not included in the total of 394 for participating in both the first and follow-up cessation support calls. At follow-up, only 1.1% patients (n = 5/440) actively refused participation in the service. The remaining 41 patients did not participate in a follow-up cessation support call due to being in hospice care or deceased (n = 12/41; 2.7%) or were unable to be reached (n = 29/41; 6.6%; ie, no answer, wrong telephone number in the EMR). There were no demographic, health behavior, or disease characteristics significantly associated with participating in the follow-up cessation support call (results not shown). There was an average of 49.3 days (SD = 98.1; median = 21 days; range, 0-742 days) between the first and follow-up cessation support calls, and an average of 1.8 call attempts made.
Impact of the cessation support service
As shown in Figure 2 , 86.8% (n = 342/394) of patients participating in 2 cessation support calls had been referred as current users and 13.2% (n = 52/394) had been referred as recent quitters. Among the 342 patients referred as current users, 20.2% (n = 69/342) reported having quit at the follow-up cessation support call. Among current users both at referral and at the first cessation support call, 14.9% (n = 47/315) reported quitting at follow-up.
The quit rate was not statistically different between those reported having recently quit at the time of referral (n = 52/394; 13.2%) and those who reported having quit at the first cessation support call (n = 54/394; 13.7%; P = .834; Figure 2 ). However, there was a significant increase in the quit rate noted at the first cessation support call (n = 54/394; 13.7%) compared with follow-up (n = 100/394; 25.4%) for patients who participated in at least 2 calls (P < .001).
After controlling for demographic and health behavior factors, marital status and ECOG performance status significantly predicted cessation at the followup cessation support call among current users at referral and first cessation support call (Table) . Married patients were more likely to report cessation at follow-up than single patients (odds ratio [OR] = 2.05; 95% confidence interval [CI], 1.01-4.18). Patients with an ECOG performance score of 0 were more likely to report cessation at follow-up than persons with an ECOG performance score of 1 or greater (OR = 4.05; 95% CI, 1.58-10.39). No covariates were statistically significant predictors of reporting cessation at follow-up for patients referred to the cessation support service as recent quitters (results not shown).
Discussion
Many patients demonstrate an interest in participating in a free, opt-out, telephone-based cessation program once successfully contacted, indicated by the nearly 90% follow-up call participation rate. Opt-out programs similar to this program design have been shown to significantly improve enrollment rates into tobacco use treatment programs compared with optin or Ask-Advise-Refer programs. 15, 16, 22 In the first 2 years of the cessation support service, only 2.3% FIGURE 2 Self-reported 7-Day Quit Rates for Thoracic Cancer Center Patients Contacted at Least Twice by the Cessation Support Service (N = 394) a a A "current user" is someone who reports using tobacco, at least a puff, in the past 7 days. A "newly quit" patient includes those who reported current use at the last contact but now reports being 7 days tobacco-free. "Maintained quit" is someone who reports the previously mentioned quit definition for the previous and current contacts. "Relapse" is someone who reports quitting at the previous contact but is now reporting current tobacco use. Follow-up time was through August 2013. Among those contacted twice, the average time to the first cessation support call was 46.1 days and was 44.6 days between the first cessation support call and follow-up. The P value for the difference between referral (n = 52/394; 13.2%) and the first cessation support call (n = 54/394; 13.7%) overall quit rates is P = .834. The P value for the difference between the first cessation support call (n = 54/394; 13.7%) and follow-up (n = 100/394; 25.4%) overall quit rates is P < .001.
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. actively refused participation at the first cessation support call and 1.1% actively refused participation at follow-up. This analysis suggests that the opt-out program experienced few patients actively refusing participation and low levels of passive refusals and that thoracic cancer center patients reached by telephone have a high level of interest in participating in the cessation service (23% did not participate in the first cessation support call and 10% did not participate in a follow-up call). This program was designed to maximize reach and participation compared with a clinical trial design. However, issues with implementation were discovered once the program began. Human resource limitations were the biggest barrier to implementing the program with maximal reach as designed. Calls were only placed to 74.9% of new patients referred to the cessation service from the thoracic cancer center, and only 60.3% of those contacted once received a followup call. Another barrier to maximizing reach was not being able to reach referred patients. Telephone numbers in the EMR were out of service, voice mails were full, patients never answered, or only family members could be reached for up to 9 contact attempts. Patients in an end-of-life situation or already deceased were not a common reason for participation despite being a sick population. Similarly, active refusals were a minimal barrier to participation.
Previous studies have shown that cancer screening or a diagnosis may be a teachable moment to encourage tobacco cessation. [3] [4] [5] Specifically looking at current tobacco users at the time of referral, 7.9% self-reported quitting between referral and the first cessation service contact, suggesting that diagnosis or cancer screening may be a teachable, motivational moment for a quit attempt for this particular group of patients. At follow-up, 14.9% of current users at both referral and first cessation support call reported abstinence, suggesting that the cessation support service may help motivate participating thoracic cancer center patients. However, it is difficult to attribute quitting solely to this 1-time cessation support contact since we did not assess other sources of cessation support and there was not a control group to serve as a comparison. Based on the results of the multivariate regression model, the cessation support service may explore the need to tailor cessation support messaging to improve the quit rates for current tobacco using patients at the first and follow-up calls. Nonmarried thoracic cancer center patients and patients with an ECOG performance score greater than 0 were less likely to quit at follow-up, so these groups could represent ideal patient cohorts who may benefit from alternative cessation approaches.
A strength of this program is the demonstrated support for the use of a standardized, clinic-based tobacco use screening program and automatic referral system to a free, opt-out, telephone-based cessation support service. The majority of the published literature relies on retrospective medical record review to extract tobacco use collected in a nonstandardized way and utilizes opt-in program designs. [23] [24] [25] The program described herein utilizes a standardized and systematic tobacco use questionnaire administered to all patients, reducing the uncontrolled variability of tobacco use typically found in retrospective medical record review.
This program implementation study experienced operational limitations. One operational limitation is that this observational study examined the referral, participation, and quit rates of thoracic cancer center patients at one institution, which limits the generalizability of the results. Another operational limitation with this program evaluation is that the data depend on nursing adherence to complete the tobacco assessment questionnaire. The tobacco use assessment was not mandatory for the beginning of the service, resulting in a smaller than expected proportion of referrals generated for thoracic cancer center patients seen from October 2010 to October 2012. There may be fundamental differences between patients automatically referred to the cessation service following the tobacco use assessment and those directly referred by the clinical staff. However, after results were examined including and excluding the 46 direct referrals and neither bivariate nor multivariate results differed, the direct referrals remained in the final sample. Limited information on other tobacco use, such as cigars and smokeless, was not available from the beginning of the service due to poor compliance with the assessment, unintentionally restricting the analyses to combustible cigarette users. However, another study at the same institute found that few adult tobacco users exclusively use noncigarette forms of tobacco. 17 To address these issues, the tobacco assessment questionnaire has been modified to be time efficient and mandatory to enhance nursing compliance.
Another operational limitation is the fact that we experienced human resource limitations at the beginning of the service. As a result, it was not possible to contact all eligible referrals or follow-up with all patients successfully contacted at least once. With only 75% of referrals having a contact attempt and 60% of those contacted successfully having a follow-up attempt, there is a clear need for adequate staffing to reach all thoracic cancer center patients referred to the service and to provide a continuum of cessation support. An immediate solution for the human resource limitations was that cessation specialists prioritized making a successful telephone call at least once to new patients referred from the thoracic cancer center as current tobacco users and then focused on established patients and those referred to the service as former smokers. The cessation support service added additional cessation specialists in 2013. We performed an intention-to-treat analysis with the regression model to address the missing data resulting from loss to follow-up and the inability to call every referral. Those indicating cessation at follow-up remained as quit, and those who were current or missing at follow-up were included as current users. The results were comparable with the regression results presented in this article, suggesting that the missing data may not be biasing the results. The variability in follow-up time creates another operational limitation; increased time between contacts also increases the chance a participant may relapse or quit on his or her own, without the assistance of the cessation service.
Two important study design limitations exist with this article. First, there was no control group to serve as a comparison for quit rates for this population since this service was designed to be a clinical program and to serve all eligible patients; however, the goal of this report is to describe participation rates and reported quit rates from this service. Second, quit status was indicated by a short-term measure (at least 7 consecutive days) and was self-reported, without biochemical confirmation. Reporting at least 7 consecutive days smoke-free does not demonstrate long-term quitting but indicates that patients are attempting to quit smoking. This limitation may result in misclassification of the outcome since cancer patients may inaccurately self-report recent quit status. 26 In the future, biochemical confirmation of self-reported quit status ought to be considered in order to gain insight into the accuracy of self-reported quit status in this particular population of thoracic cancer center patients. Similarly, longer-term quit rates should be considered as an outcome measure.
It is imperative to analyze the longer-term effectiveness of this program since the teachable moment at diagnosis or cancer screening may be a 
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Implications for Policy & Practice
■ Tobacco use is a significant public health problem. 1 ■ Thoracic cancer center patients seen at an oncology center are amenable to a free, opt-out, telephone-based cessation support service, as identified by high participation rates and minimal patients refusing participation.
■ Thoracic cancer center patients participating in this cessation support service are attempting to quit using tobacco products.
■ Our study offers data other organizations may find useful while implementing a systematic way to identify tobaccousing patients as part of routine care and to improve cessation support services available to tobacco-using patients.
motivator for cessation efforts among thoracic cancer center patients. To improve the cessation service, it is essential to understand program design elements that will increase patient interest in the service, enhance compliance with cessation specialists providing and patients participating in cessation counseling calls, and generate optimal quit rates in an efficient manner.
Conclusion
Thoracic cancer center patients referred to and called by a cessation service demonstrated an interest in a telephone-based cessation support service by participating in the telephone calls and having low opt-out rates. Self-reported quit rates increased at each contact. The results suggest that for current users at referral and first contact, being married and having a lower performance status are most likely to self-report having quit for at least 7 days at follow-up.
